List of works - Michael W Konstan

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities ⬇️

scientific article published on December 1, 2001

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations ⬇️

scientific article published on October 6, 2010

Association of High-Dose Ibuprofen Use, Lung Function Decline, and Long-Term Survival in Children with Cystic Fibrosis

scientific article published on 9 January 2018

Comparison of FEV1 reference equations for evaluating a cystic fibrosis therapeutic intervention

scientific article

Current understanding of the inflammatory process in cystic fibrosis: Onset and etiology ⬇️

scientific article published on August 1, 1997

Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen change

scientific article

Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa ⬇️

scientific article published on December 1, 1997

Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing

scientific article published on 31 March 2022

Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening ⬇️

scientific article published on April 14, 2011

Inhaled Hypertonic Saline in Infants and Young Children With Cystic Fibrosis ⬇️

scientific article published on June 6, 2012

Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis

scientific article published on 20 November 2019

Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis ⬇️

scientific article published on March 23, 2012

Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection ⬇️

scientific article published on 08 June 2013

Risk factors for mortality before age 18 years in cystic fibrosis

scientific article published on 24 April 2017

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial ⬇️

scientific article published on November 12, 2010

Therapies aimed at airway inflammation in cystic fibrosis ⬇️

scientific article published on 01 September 1998

Tobramycin inhalation powder manufactured by improved process in cystic fibrosis: the randomized EDIT trial ⬇️

scientific article published on June 5, 2013

List of works by Michael W Konstan